论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Shen Y, Huang S, Kang J, Lin J, Lai K, Sun Y, Xiao W, Yang L, Yao W, Cai S, Huang K, Wen F
Received 19 June 2017
Accepted for publication 10 November 2017
Published 30 January 2018 Volume 2018:13 Pages 399—407
DOI https://doi.org/10.2147/COPD.S144312
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Charles Downs
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Chunxue Bai
Abstract: Airway mucus hypersecretion is one of the most important
characteristics of chronic airway inflammatory diseases. Evaluating and
managing airway mucus hypersecretion is of great importance for patients with
chronic airway inflammatory diseases. This consensus statement describes the
pathogenesis, clinical features, and the management of airway mucus
hypersecretion in patients with chronic airway inflammatory diseases in the
People’s Republic of China. The statement has been written particularly for
respiratory researchers, pulmonary physicians, and patients.
Keywords: mucus, COPD,
asthma, bronchiectasis, cystic fibrosis, treatment